APH1B expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 1.379820E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
8.072600E-01
Normal-vs-Stage2
1.445640E-02
Normal-vs-Stage3
2.536000E-02
Normal-vs-Stage4
1.881190E-01
Stage1-vs-Stage2
2.465000E-01
Stage1-vs-Stage3
1.522840E-01
Stage1-vs-Stage4
3.520800E-01
Stage2-vs-Stage3
2.039800E-01
Stage2-vs-Stage4
4.344800E-01
Stage3-vs-Stage4
9.441600E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
1.748150E-01
Normal-vs-AfricanAmerican
9.753900E-02
Normal-vs-Asian
5.262500E-03
Caucasian-vs-AfricanAmerican
6.875200E-01
Caucasian-vs-Asian
6.225700E-02
AfricanAmerican-vs-Asian
2.239600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
8.447600E-02
Normal-vs-Female
2.286200E-01
Male-vs-Female
3.026000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
5.428000E-01
Normal-vs-Age(41-60Yrs)
2.689400E-01
Normal-vs-Age(61-80Yrs)
4.697700E-02
Normal-vs-Age(81-100Yrs)
3.684900E-03
Age(21-40Yrs)-vs-Age(41-60Yrs)
4.174600E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
3.574200E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
3.306600E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
2.594200E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
1.006230E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
2.722600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
7.335900E-03
Normal-vs-Daily Drinker
1.005820E-01
Normal-vs-Weekly Drinker
1.118080E-02
Normal-vs-Occasional Drinker
3.645200E-01
Normal-vs-Social Drinker
4.315200E-01
Non Drinker-vs-Daily Drinker
1.959600E-01
Non Drinker-vs-Weekly Drinker
9.706400E-01
Non Drinker-vs-Occasional Drinker
1.181580E-01
Non Drinker-vs-Social Drinker
1.841410E-01
Daily Drinker-vs-Weekly Drinker
2.865600E-01
Daily Drinker-vs-Occasional Drinker
5.010000E-01
Daily Drinker-vs-Social Drinker
5.241200E-01
Weekly Drinker-vs-Occasional Drinker
1.332770E-01
Weekly Drinker-vs-Social Drinker
1.935190E-01
Occasional Drinker-vs-Social Drinker
9.783200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
2.802600E-01
Normal-vs-Grade 2
1.225610E-01
Normal-vs-Grade 3
1.294430E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
8.318200E-02
Grade 1-vs-Grade 3
6.415900E-02
Grade 1-vs-Grade 4
2.802600E-01
Grade 2-vs-Grade 3
6.798600E-01
Grade 2-vs-Grade 4
1.225610E-01
Grade 3-vs-Grade 4
1.294430E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
2.621700E-02
Normal-vs-NonDiabetic
1.836410E-01
Diabetic-vs-NonDiabetic
2.003200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
3.042300E-03
Normal-vs-NoPancreatitis
1.563970E-01
Pancreatitis-vs-NoPancreatitis
6.656200E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
2.779600E-01
Normal-vs-N1
1.716320E-02
N0-vs-N1
2.451200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
1.652030E-01
Normal-vs-TP53-NonMutant
5.796800E-01
TP53-Mutant-vs-TP53-NonMutant
2.618000E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
